TNF and colitis: While upon colitis induction, TNBS increased the expression of TNF-α and markers of a M1 phenotype and reduced the expression of IL-10, and markers of M2 phenotype and FoxP3 (Figures 4A–F), this pattern was fully reversed by treatment with VSL#3-A, while VSL#3-B had no effect.